Westfield Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-548,870
| Closed | -$20.9M | – | 244 |
|
|
2023
Q3 | $20.9M | Sell |
548,870
-47,362
| -8% | -$1.8M | 0.14% | 168 |
|
|
2023
Q2 | $54.3M | Sell |
596,232
-196,014
| -25% | -$17.9M | 0.35% | 108 |
|
|
2023
Q1 | $52.3M | Buy |
792,246
+102,769
| +15% | +$6.78M | 0.37% | 109 |
|
|
2022
Q4 | $35.7M | Buy |
+689,477
| New | +$35.7M | 0.28% | 124 |
|
|
2020
Q1 | – | Sell |
-395,490
| Closed | -$12.1M | – | 218 |
|
|
2019
Q4 | $12.1M | Buy |
395,490
+101,589
| +35% | +$3.11M | 0.09% | 182 |
|
|
2019
Q3 | $7.08M | Sell |
293,901
-88,311
| -23% | -$2.13M | 0.06% | 196 |
|
|
2019
Q2 | $9.69M | Sell |
382,212
-349,239
| -48% | -$8.85M | 0.07% | 196 |
|
|
2019
Q1 | $14.3M | Sell |
731,451
-36,425
| -5% | -$710K | 0.11% | 191 |
|
|
2018
Q4 | $10.1M | Buy |
767,876
+155,580
| +25% | +$2.05M | 0.09% | 188 |
|
|
2018
Q3 | $10.9M | Buy |
612,296
+5,340
| +0.9% | +$94.9K | 0.08% | 196 |
|
|
2018
Q2 | $13.4M | Buy |
+606,956
| New | +$13.4M | 0.1% | 198 |
|